LISATA THERAP.INC.DL-001 (8NE) — Financial Flexibility Index
LISATA THERAP.INC.DL-001 (8NE) has a Financial Flexibility Index of -0.87x as of June 2026. Free cash flow of €-2.65 Million (operating CF €-2.65 Million minus capex €0.00) represents -1% of total liabilities (€3.04 Million). Check 8NE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LISATA THERAP.INC.DL-001 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LISATA THERAP.INC.DL-001 across 5 annual periods. For the full cash flow conversion analysis, see 8NE operating cash flow.
Annual Financial Flexibility Index for LISATA THERAP.INC.DL-001 (2021–2025)
Year-by-year free cash flow to debt coverage for LISATA THERAP.INC.DL-001. Explore 8NE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.07x | €-15.92 Million | €-15.95 Million | €3.14 Million | ▼ -48.8% |
| 2024 | -3.40x | €-19.36 Million | €-19.36 Million | €5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | €-20.03 Million | €-20.03 Million | €6.80 Million | ▲ +5.4% |
| 2022 | -3.11x | €-20.89 Million | €-21.17 Million | €6.71 Million | ▲ +29.7% |
| 2021 | -4.43x | €-22.18 Million | €-22.25 Million | €5.01 Million | — |